
### [NCIT:C80280](http://purl.obolibrary.org/obo/NCIT_C80280)
**Label:** Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C45231](http://purl.obolibrary.org/obo/NCIT_C45231) (Diffuse Large B-Cell Lymphoma Unclassifiable), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8124](http://purl.obolibrary.org/obo/NCIT_C8124) (Stage II Adult Immunoblastic Lymphoma), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7873](http://purl.obolibrary.org/obo/NCIT_C7873) (Adult Immunoblastic Lymphoma), [NCIT:C7263](http://purl.obolibrary.org/obo/NCIT_C7263) (Thyroid Gland Immunoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074) (Centroblastic Lymphoma), [NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type), [NCIT:C3461](http://purl.obolibrary.org/obo/NCIT_C3461) (Immunoblastic Lymphoma), [NCIT:C36080](http://purl.obolibrary.org/obo/NCIT_C36080) (Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C45219](http://purl.obolibrary.org/obo/NCIT_C45219) (Diffuse Large B-Cell Lymphoma by Gene Expression Profile), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C6916](http://purl.obolibrary.org/obo/NCIT_C6916) (Anaplastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36495](http://purl.obolibrary.org/obo/NCIT_C36495) (Trisomy 2))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36493](http://purl.obolibrary.org/obo/NCIT_C36493) (High-Frequency Microsatellite Instability))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36491](http://purl.obolibrary.org/obo/NCIT_C36491) (Loss of Chromosome 22))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36490](http://purl.obolibrary.org/obo/NCIT_C36490) (Loss of Chromosome 14))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36489](http://purl.obolibrary.org/obo/NCIT_C36489) (Gain of Chromosome 5p))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36488](http://purl.obolibrary.org/obo/NCIT_C36488) (Gain of Chromosome 8q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36487](http://purl.obolibrary.org/obo/NCIT_C36487) (Gain of Chromosome 3q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36486](http://purl.obolibrary.org/obo/NCIT_C36486) (Gain of Chromosome 5))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36485](http://purl.obolibrary.org/obo/NCIT_C36485) (CCND1 Protein Overexpression))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36484](http://purl.obolibrary.org/obo/NCIT_C36484) (Gain of Chromosome 17q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36483](http://purl.obolibrary.org/obo/NCIT_C36483) (Gain of Chromosome 9q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36482](http://purl.obolibrary.org/obo/NCIT_C36482) (Gain of Chromosome 1q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36481](http://purl.obolibrary.org/obo/NCIT_C36481) (Gain of Chromosome 15q))) 56.54%
- [NCIT:C36337](http://purl.obolibrary.org/obo/NCIT_C36337) (Messenger RNA Overexpression) and (not ([NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q))) 56.54%


